🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The ALS Canada Board Members visited Dr @JanuceRobertson’s lab at University of Toronto Tanz Centre this week. Fantastic opportunity to learn about the research ALS Canada has funded and to meet the talented researchers behind the work. Thank you! #dedication #inspiration #AFutureWithoutALS

First three teams have pitched at the Building a Biotech Venture Pitch Competition! ➡️Drug discovery team CApt Dynamics Shana Kelley lab. ➡️Cell therapies team Myoxa Therapeutics Garton Lab. ➡️Small molecule development team Neuropeutics @JanuceRobertson lab.

🥈 Place Award on developing new treatment options for ALS #ICAIR2023

Thrilled to have been selected to join this program to further grow our venture NEUROPEUTICS developing therapies for ALS and other neurodegenerative diseases.

Had an exceptional 2 weeks at #SummerbyDesign program learning about drug commercialization, and the biotech ecosystem in Toronto and beyond. New friendships and invaluable business connections were made!

Participating in the program has been an invaluable opportunity for my venture Neuropeutics and personal growth. The curriculum and expert mentorship provide the perfect platform to refine our strategies, explore new perspectives, and fine-tune our business model.

Through my PhD, I have identified and validated a small molecule, with a novel mechanism of action, which offers hope in the fight against ALS. Now, I am continuing to develop it under our new startup Neuropeutics Inc. lmp.utoronto.ca/news/breakthro…

🔬Marc Shenouda, PhD and @JanuceRobertson, aim to bring hope to ALS patients. Their team at Tanz Centre at University of Toronto has discovered a groundbreaking molecule. With Connaught Award support, they hope to revolutionize ALS treatment. lmp.utoronto.ca/news/breakthro…

🧠 Breakthrough molecule offers hope in fight against ALS lmp.utoronto.ca/news/breakthro… @JanuceRobertson Marc Shenouda, PhD

I am thrilled to announce that our company Neuropeutics has been chosen among the top 5 finalists in the Desjardins Pitch Competition on March 7th from 12-2pm. I encourage you to come support us in person during the event. neuropeutics.ca lnkd.in/gAqE82DH

Neuropeutics won 2nd Place Award and People’s Choice Award at University of Toronto Entrepreneurship and Desjardins Pitch Competition! Connect with us: neuropeutics.ca

Looking forward to attending and presenting at the 2024 International Society of Frontotemporal Dementia in Amsterdam!

Neuropeutics, co-founded by #TemertyMed's Janice Robertson and Marc Shenouda, is joining forces with LifeArc to develop new treatment for motor neuron disease/ALS. bit.ly/3CqHRaP

My company Neuropeutics Inc has partnered with medical research charity LifeArc to develop a new drug for ALS. Connect with us to join our mission! Read more: lnkd.in/gnvgDvQc